X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFESCIENCES NATCO PHARMA SUVEN LIFESCIENCES/
NATCO PHARMA
 
P/E (TTM) x 20.5 10.7 191.7% View Chart
P/BV x 3.9 2.9 135.2% View Chart
Dividend Yield % 0.6 1.6 37.9%  

Financials

 SUVEN LIFESCIENCES   NATCO PHARMA
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-18
NATCO PHARMA
Mar-18
SUVEN LIFESCIENCES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs2511,080 23.2%   
Low Rs155671 23.1%   
Sales per share (Unadj.) Rs49.1592.1 8.3%  
Earnings per share (Unadj.) Rs9.7188.4 5.2%  
Cash flow per share (Unadj.) Rs11.4206.3 5.5%  
Dividends per share (Unadj.) Rs1.508.25 18.2%  
Dividend yield (eoy) %0.70.9 78.5%  
Book value per share (Unadj.) Rs60.3833.6 7.2%  
Shares outstanding (eoy) m127.2836.90 344.9%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.11.5 279.3%   
Avg P/E ratio x20.94.6 449.2%  
P/CF ratio (eoy) x17.84.2 419.7%  
Price / Book Value ratio x3.41.1 320.4%  
Dividend payout %15.44.4 352.5%   
Avg Mkt Cap Rs m25,82532,311 79.9%   
No. of employees `0001.14.8 22.2%   
Total wages/salary Rs m6133,256 18.8%   
Avg. sales/employee Rs Th5,832.64,522.5 129.0%   
Avg. wages/employee Rs Th571.5674.0 84.8%   
Avg. net profit/employee Rs Th1,153.81,439.0 80.2%   
INCOME DATA
Net Sales Rs m6,25321,848 28.6%  
Other income Rs m233404 57.6%   
Total revenues Rs m6,48522,252 29.1%   
Gross profit Rs m1,9829,284 21.3%  
Depreciation Rs m213662 32.2%   
Interest Rs m46154 30.1%   
Profit before tax Rs m1,9558,872 22.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7181,920 37.4%   
Profit after tax Rs m1,2376,952 17.8%  
Gross profit margin %31.742.5 74.6%  
Effective tax rate %36.721.6 169.8%   
Net profit margin %19.831.8 62.2%  
BALANCE SHEET DATA
Current assets Rs m5,62221,307 26.4%   
Current liabilities Rs m1,1685,920 19.7%   
Net working cap to sales %71.270.4 101.2%  
Current ratio x4.83.6 133.8%  
Inventory Days Days8173 111.2%  
Debtors Days Days36107 33.7%  
Net fixed assets Rs m3,32514,986 22.2%   
Share capital Rs m127369 34.5%   
"Free" reserves Rs m7,54730,353 24.9%   
Net worth Rs m7,67430,760 24.9%   
Long term debt Rs m140-   
Total assets Rs m9,13537,151 24.6%  
Interest coverage x43.258.6 73.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 116.4%   
Return on assets %14.019.1 73.4%  
Return on equity %16.122.6 71.3%  
Return on capital %26.029.3 88.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m5,06610,322 49.1%   
Fx outflow Rs m2,0012,978 67.2%   
Net fx Rs m3,0657,343 41.7%   
CASH FLOW
From Operations Rs m6994,636 15.1%  
From Investments Rs m-6-11,155 0.1%  
From Financial Activity Rs m-5776,509 -8.9%  
Net Cashflow Rs m116-18 -646.1%  

Share Holding

Indian Promoters % 63.4 52.0 121.8%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 0.0 7.8 -  
FIIs % 0.0 16.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 26.0 140.4%  
Shareholders   37,287 25,395 146.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFESCIENCES With:   TTK HEALTHCARE  ALEMBIC LTD  CIPLA  ELDER PHARMA  VENUS REMEDIES  

Compare SUVEN LIFESCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Hit Record High as Exit Polls Predict NDA Win; Sensex Ends 1,421 Points Higher(Closing)

Indian share markets witnessed huge buying interest today. The benchmark indices opened gap-up after Exit Polls for the Lok Sabha Elections 2019.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 115.2% YoY). Sales on the other hand came in at Rs 5 bn (up 27.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

A 10-Bagger in Just 6 Years! The Rebirth of India Will Create More Big Winners Like This(The 5 Minute Wrapup)

May 7, 2019

How a niche tech startup battled all odds to eventually become a 10 bagger.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFESCIENCES SHARE PRICE


May 20, 2019 03:37 PM

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES - WOCKHARDT COMPARISON

COMPARE SUVEN LIFESCIENCES WITH

MARKET STATS